Physician
Southwest Pediatric and Family Care, LLC
Southwest Pediatric and Family Care, LLC was paid $7.51M by Medicaid between Jan 2018 and Dec 2024, across 102 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoSOUTHWEST PEDIATRIC AND FAMILY CARE, LLC
DEMING, NM 88030
DEMING, NM 88030
33aNPI1881089886assigned 04/06/2015
33bProvider typePediatrics Physician
28Total paid$7.51M
24GClaims181,568
24DCodes billed102
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in New Mexico
Rank by total paid#6 of 53
Median peer was paid$535K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,918 | $565K | |
| 2019 | 19,993 | $676K | |
| 2020 | 17,521 | $613K | |
| 2021 | 23,462 | $782K | |
| 2022 | 28,544 | $1.06M | |
| 2023 | 34,552 | $1.52M | |
| 2024incomplete | 38,578 | $2.29M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 21,956 | 18,572 | $1.82M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 17,077 | 14,341 | $1.76M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.8% | 3,242 | 3,185 | $359K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.6% | 6,781 | 6,728 | $349K |
| 99442 | 4.5% | 3,205 | 2,913 | $340K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.7% | 2,622 | 2,423 | $274K |
| 90461 | 3.3% | 3,739 | 3,721 | $247K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.2% | 5,740 | 4,517 | $243K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.2% | 2,314 | 2,307 | $239K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.8% | 5,610 | 5,515 | $213K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.0% | 828 | 755 | $152K |
| 99177 | 1.9% | 4,894 | 4,877 | $141K |
90 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.7% | 1,238 | $128K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 2,428 | $110K |
| 87634 | 1.1% | 1,202 | $84K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 5,994 | $82K |
| 99173 | <1% | 2,606 | $72K | |
| 88738 | <1% | 13,101 | $66K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 584 | $61K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,105 | $58K |
| 99422 | <1% | 763 | $46K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 418 | $42K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 153 | $40K |
| 83655 | <1% | 2,924 | $39K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,995 | $38K |
| Q3014 | Telehealth originating site facility fee | <1% | 1,336 | $38K |
| 90837 | Psychotherapy session, about an hour | <1% | 226 | $36K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,305 | $30K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,896 | $30K |
| 86328 | <1% | 628 | $29K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 195 | $29K |
| 82962 | <1% | 8,113 | $28K | |
| 85018 | <1% | 9,047 | $23K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 738 | $22K |
| 80305 | <1% | 1,303 | $17K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 681 | $16K |
| 92551 | <1% | 1,410 | $16K | |
| S9999 | Sales tax | <1% | 1,631 | $15K |
| 87631 | <1% | 82 | $14K | |
| 99050 | <1% | 1,226 | $14K | |
| 81003 | <1% | 6,628 | $13K | |
| 90686 | <1% | 1,837 | $13K | |
| 99443 | <1% | 92 | $12K | |
| 99080 | <1% | 1,770 | $12K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 55 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,572 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 977 | $10K |
| 86769 | <1% | 209 | $9K | |
| 99205 | Prolong outpt/office vis | <1% | 41 | $9K |
| 99441 | <1% | 176 | $9K | |
| 80061 | Lipid panel | <1% | 635 | $8K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 44 | $4K |
| 87807 | <1% | 291 | $4K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 15 | $4K |
| H0033 | Oral medication administration, direct observation | <1% | 101 | $3K |
| 99382 | <1% | 14 | $2K | |
| 99381 | <1% | 13 | $2K | |
| 99072 | <1% | 4,516 | $2K | |
| 90670 | <1% | 1,120 | $1K | |
| 81001 | <1% | 389 | $1K | |
| 94760 | <1% | 3,772 | $1K | |
| 90473 | <1% | 64 | $929.49 | |
| 92552 | <1% | 49 | $838.25 | |
| 92567 | <1% | 38 | $534.66 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 350 | $502.89 |
| 36416 | <1% | 2,234 | $460.66 | |
| 90651 | <1% | 290 | $383.10 | |
| 90656 | <1% | 74 | $324.40 | |
| 99188 | <1% | 41 | $320.00 | |
| 90734 | <1% | 134 | $275.28 | |
| 90681 | <1% | 380 | $266.66 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 25 | $259.45 |
| 90688 | <1% | 14 | $210.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 327 | $163.52 |
| 90647 | <1% | 1,110 | $135.27 | |
| 81025 | <1% | 14 | $118.39 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 60 | $86.51 |
| 90723 | <1% | 454 | $63.72 | |
| J0290 | Injection, ampicillin sodium, 500 mg | <1% | 31 | $62.56 |
| 90633 | <1% | 603 | $37.17 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 12 | $1.05 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 1,089 | $0.00 |
| 3044F | 0% | 723 | $0.00 | |
| 90677 | 0% | 399 | $0.00 | |
| 1036F | 0% | 1,516 | $0.00 | |
| A9150 | Non-prescription drugs | 0% | 51 | $0.00 |
| 90696 | 0% | 30 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 95 | $0.00 |
| 90698 | 0% | 34 | $0.00 | |
| 90620 | 0% | 37 | $0.00 | |
| E0570 | Nebulizer, with compressor | 0% | 14 | $0.00 |
| 90716 | 0% | 24 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 1,097 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 1,604 | $0.00 |
| 90710 | 0% | 330 | $0.00 | |
| 90671 | 0% | 203 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 253 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 108 | $0.00 |
| D0415 | 0% | 18 | $0.00 | |
| 90715 | 0% | 12 | $0.00 | |
| 90707 | 0% | 12 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROQUE, JOEL (COO / CO-OWNER)